NCT01536678View on ClinicalTrials.gov

Bioequivalence of Two Levothyroxine Tablet Formulations in Healthy Indian Volunteers

PHASE4CompletedINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

January 31, 2012

Primary Completion Date

April 30, 2012

Study Completion Date

April 30, 2012

Conditions
Hypothyroidism
Interventions
DRUG

Levothyroxine

Single dose of 600mcg of test formulation of levothyroxine administered in dosing period 1 or 2.

DRUG

Levothyroxine

Single dose of 600mcg of reference formulation of levothyroxine administered in dosing period 1 or 2.

Trial Locations (1)

500051

GSK Investigational Site, Hyderabad

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY

NCT01536678 - Bioequivalence of Two Levothyroxine Tablet Formulations in Healthy Indian Volunteers | Biotech Hunter | Biotech Hunter